Home/Filings/5/A/0001437749-21-013627
5/A//SEC Filing

Tarrabain Alex 5/A

Accession 0001437749-21-013627

CIK 0001653821other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 8:31 AM ET

Size

5.2 KB

Accession

0001437749-21-013627

Insider Transaction Report

Form 5/AAmended
Period: 2017-12-31
Tarrabain Alex
DirectorChief Financial Officer
Transactions
  • Award

    Common Stock

    2017-11-30+20,00099,942 total
Footnotes (2)
  • [F1]20,000 shares of common stock of the issuer were granted by the issuer on November 30, 2017, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
  • [F2]99,942 shares were beneficially owned by the Reporting Person of which 30,000 shares were issuable upon conversion of a convertible note held by the Reporting Person at 12/31/2017.

Documents

1 file

Issuer

CEN BIOTECH INC

CIK 0001653821

Entity typeother

Related Parties

1
  • filerCIK 0001736937

Filing Metadata

Form type
5/A
Filed
May 27, 8:00 PM ET
Accepted
May 28, 8:31 AM ET
Size
5.2 KB